Minerva Surgical (UTRS) Ratios
Minerva Surgical Ratios
UTRS's free cash flow for Q3 2023 was $-5.11M. For the 2023 fiscal year, UTRS's free cash flow was decreased by $-17.00K and operating cash flow was $-5.09M. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 2.53 | 3.29 | 1.37 | 2.88 |
| Quick Ratio | 1.35 | 2.60 | 1.06 | 2.57 |
| Cash Ratio | 0.49 | 1.78 | 0.52 | 1.78 |
| Solvency Ratio | -0.45 | -0.15 | -0.04 | -0.20 |
| Operating Cash Flow Ratio | -2.49 | -0.98 | -0.37 | -1.30 |
| Short-Term Operating Cash Flow Coverage | -18.78 | -118.41 | -7.34 | 0.00 |
| Net Current Asset Value | $ -15.60M | $ 4.02M | $ -268.44M | $ -207.39M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.58 | 0.34 | 1.06 | 1.63 |
| Debt-to-Equity Ratio | 2.31 | 0.89 | -0.44 | -0.37 |
| Debt-to-Capital Ratio | 0.70 | 0.47 | -0.78 | -0.59 |
| Long-Term Debt-to-Capital Ratio | 0.69 | 0.47 | -0.76 | -0.59 |
| Financial Leverage Ratio | 4.01 | 2.61 | -0.41 | -0.23 |
| Debt Service Coverage Ratio | -3.93 | 0.07 | 0.07 | -1.00 |
| Interest Coverage Ratio | -9.59 | -2.49 | -1.27 | -1.12 |
| Debt to Market Cap | 6.12 | 0.27 | 0.53 | 0.45 |
| Interest Debt Per Share | 29.79 | 35.60 | 107.29 | 100.83 |
| Net Debt to EBITDA | -1.63 | -1.49 | 97.35 | -2.76 |
| Profitability Margins | ||||
| Gross Profit Margin | 54.17% | 58.58% | 50.62% | 45.38% |
| EBIT Margin | -61.40% | -18.67% | -16.56% | -132.50% |
| EBITDA Margin | -39.91% | 1.71% | 2.17% | -67.88% |
| Operating Profit Margin | -61.44% | -55.94% | -40.75% | -75.49% |
| Pretax Profit Margin | -67.80% | -41.18% | -48.71% | -200.08% |
| Net Profit Margin | -67.83% | -41.20% | -48.36% | -200.08% |
| Continuous Operations Profit Margin | -67.83% | -41.20% | -48.36% | -200.08% |
| Net Income Per EBT | 100.03% | 100.04% | 99.28% | 100.00% |
| EBT Per EBIT | 110.36% | 73.61% | 119.53% | 265.04% |
| Return on Assets (ROA) | -49.51% | -18.65% | -19.84% | -111.49% |
| Return on Equity (ROE) | -198.54% | -48.67% | 8.23% | 25.45% |
| Return on Capital Employed (ROCE) | -56.57% | -31.58% | -26.18% | -62.42% |
| Return on Invested Capital (ROIC) | -54.33% | -31.52% | -25.28% | -62.42% |
| Return on Tangible Assets | -80.98% | -26.79% | -37.34% | -111.49% |
| Earnings Yield | -530.99% | -14.57% | -9.95% | -31.19% |
| Efficiency Ratios | ||||
| Receivables Turnover | 6.94 | 7.15 | 4.51 | 6.59 |
| Payables Turnover | 8.22 | 5.95 | 5.32 | 3.39 |
| Inventory Turnover | 1.37 | 1.38 | 1.83 | 2.99 |
| Fixed Asset Turnover | 9.47 | 11.34 | 13.11 | 11.48 |
| Asset Turnover | 0.73 | 0.45 | 0.41 | 0.56 |
| Working Capital Turnover Ratio | 1.36 | 1.62 | 1.85 | 0.00 |
| Cash Conversion Cycle | 274.97 | 254.95 | 212.02 | 69.54 |
| Days of Sales Outstanding | 52.57 | 51.08 | 80.98 | 55.38 |
| Days of Inventory Outstanding | 266.80 | 265.24 | 199.67 | 121.88 |
| Days of Payables Outstanding | 44.40 | 61.38 | 68.62 | 107.72 |
| Operating Cycle | 319.37 | 316.33 | 280.64 | 177.27 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -24.69 | -15.62 | -12.00 | -21.35 |
| Free Cash Flow Per Share | -24.74 | -16.03 | -12.45 | -21.59 |
| Dividend Paid and CapEx Coverage Ratio | -487.22 | -38.32 | -27.02 | -88.75 |
| Capital Expenditure Coverage Ratio | -487.22 | -38.32 | -27.02 | -88.75 |
| Operating Cash Flow Coverage Ratio | -0.90 | -0.57 | -0.13 | -0.26 |
| Operating Cash Flow to Sales Ratio | -0.71 | -0.43 | -0.32 | -0.76 |
| Free Cash Flow Yield | -554.77% | -15.59% | -6.91% | -11.99% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -0.19 | -6.86 | -10.05 | -3.21 |
| Price-to-Sales (P/S) Ratio | 0.13 | 2.83 | 4.86 | 6.41 |
| Price-to-Book (P/B) Ratio | 0.37 | 3.34 | -0.83 | -0.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.18 | -6.41 | -14.46 | -8.34 |
| Price-to-Operating Cash Flow Ratio | -0.18 | -6.58 | -15.00 | -8.43 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.42 | 0.13 | 0.00 |
| Enterprise Value Multiple | -1.95 | 163.42 | 320.97 | -12.22 |
| Enterprise Value | 39.17M | 145.93M | 263.52M | 215.67M |
| EV to EBITDA | -1.95 | 163.42 | 320.97 | -12.22 |
| EV to Sales | 0.78 | 2.80 | 6.98 | 8.29 |
| EV to Free Cash Flow | -1.10 | -6.36 | -20.76 | -10.78 |
| EV to Operating Cash Flow | -1.10 | -6.52 | -21.53 | -10.90 |
| Tangible Book Value Per Share | -6.66 | 6.38 | -259.77 | -220.62 |
| Shareholders’ Equity Per Share | 11.93 | 30.79 | -217.47 | -220.62 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | -0.00 | -0.00 | 0.01 | 0.00 |
| Revenue Per Share | 34.92 | 36.37 | 37.03 | 28.06 |
| Net Income Per Share | -23.68 | -14.98 | -17.91 | -56.14 |
| Tax Burden | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.10 | 2.21 | 2.94 | 1.51 |
| Research & Development to Revenue | 0.11 | 0.10 | 0.09 | 0.04 |
| SG&A to Revenue | 0.29 | 0.43 | 0.22 | 0.32 |
| Stock-Based Compensation to Revenue | 0.14 | 0.13 | 0.02 | 0.02 |
| Income Quality | 1.04 | 1.04 | 0.67 | 0.38 |
Currency in USD
